| General Information of This Metabolic Reaction (MR) (ID:
MR013682) |
| Formula |
|
| Reactant |
Enzalutamide metabolite M6 enzalutamide |
Product |
N-desmethyl enzalutamide |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
|
Metabolic Type
|
Oxidation
-
Demethylation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Produce The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
|
| References |
| 1 |
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
|
| 2 |
Clinical Pharmacokinetic Studies of Enzalutamide
|
| 3 |
Absorption, Distribution, Metabolism, and Excretion of the Androgen Receptor Inhibitor Enzalutamide in Rats and Dogs
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.